Medical Devices New Zealand

New Zealand Myopia Control Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

New Zealand Myopia Control Market Industry Trends and Forecast to 2034: Segmented by (Product, Age, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

New Zealand · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $37.5 Mn Placeholder estimate
Estimate 2025 $43.0 Mn 1.1% of the global market
Projected 2034 $150.2 Mn 249% Adds $107.2 Mn over 9 forecast years
CAGR 2025–2034 14.9% Faster than 85% of 147 Medical Devices markets here
Key players 5
  • New Zealand is 1.08% of the global market.
  • In APAC, the largest is China at $284.4 Mn.
  • Fastest growing: India at 18.2% a year.
  • New Zealand ranks 4th of 10 by size in APAC.

Market size projection

New Zealand

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$107.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Myopia Control Market market size by year, New Zealand
YearMarket sizeChange that yearSince 2025
2024 (estimate) $37.5 Mn — —
2025 (base) $43.0 Mn +$5.6 Mn —
2026 (forecast) $49.5 Mn +$6.4 Mn +14.9%
2027 (forecast) $56.8 Mn +$7.4 Mn +32%
2028 (forecast) $65.3 Mn +$8.5 Mn +51.7%
2029 (forecast) $75.0 Mn +$9.7 Mn +74.3%
2030 (forecast) $86.2 Mn +$11.2 Mn +100.3%
2031 (forecast) $99.0 Mn +$12.8 Mn +130.1%
2032 (forecast) $113.8 Mn +$14.8 Mn +164.4%
2033 (forecast) $130.7 Mn +$17.0 Mn +203.8%
2034 (forecast) $150.2 Mn +$19.5 Mn +249%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

New Zealand Myopia Control Market Analysis at a glance
Market size, 2025$43.0 Mn placeholder estimate
Forecast, 2034$150.2 Mn placeholder estimate
Growth (CAGR), 2025–203414.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, age and end user (see all)
Key playersEssilorLuxottica, HOYA, CooperVision, Johnson & Johnson, Santen Pharmaceutical Co Ltd (see all)
Regulator in New ZealandMedsafe (WAND)Source: Medsafe. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The New Zealand Myopia Control Market Analysis Executive Summary

Myopia control slows short-sightedness getting worse in children, using special glasses, contact lenses and eye drops.

Key segments of the myopia Control market include product (Myopia Control Spectacle Lenses, Orthokeratology Lenses and Soft Multifocal Contact Lenses) and age (Children and Teenagers).

Bar chart: New Zealand Myopia Control market size, 2024–2034, placeholder estimates. $37.5 Mn in 2024, $43.0 Mn in 2025 and $150.2 Mn in 2034, 14.9% CAGR.
New Zealand Myopia Control market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

New Zealand Myopia Control Market Dynamics

Market Growth Drivers

An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the myopia Control market.

Opportunity

Longer-acting treatments, home-based care and screening in emerging markets give the myopia Control market room to grow.

Market Restraints

High costs of new treatments, specialist shortages, low awareness and limited reimbursement in some countries hold back the myopia Control market.

Competitive Landscape for Myopia Control Market in New Zealand

The myopia Control market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Myopia Control Market in New Zealand

Myopia Control in New Zealand: rules and payment

Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe.⁠[1] Pharmac decides which medicines and medical devices the public health system pays for.⁠[2]

[1] Medsafe. Checked 14 Nov 2026.

[2] Pharmac. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how myopia Control products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in New Zealand.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Myopia Control right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Myopia Control in context

New Zealand compared

  • Health spending per person: 5,022 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.61 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 2nd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 17.6% of people (2025). World: 10.4% of people (2025). 4th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Myopia Control market in New Zealand?
Placeholder estimate: about $43.0 Mn in 2025, rising to about $150.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Myopia Control market in New Zealand growing?
Placeholder estimate: about 14.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Myopia Control market report cover?
The report splits the market by product (Myopia Control Spectacle Lenses, Orthokeratology Lenses, Soft Multifocal Contact Lenses, Low-Dose Atropine), age (Children, Teenagers) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Myopia Control market?
Key players include EssilorLuxottica, HOYA, CooperVision, Johnson & Johnson and Santen Pharmaceutical Co Ltd.
What is driving the Myopia Control market?
An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the myopia Control market.
Who regulates Myopia Control in New Zealand?
Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe. Source: Medsafe. Checked 14 Nov 2026.
How is healthcare paid for in New Zealand?
Pharmac decides which medicines and medical devices the public health system pays for. Source: Pharmac. Checked 14 Nov 2026.
How much research is published on Myopia Control?
PubMed lists 1,160 papers on Myopia Control added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in New Zealand

See all

Related on eye health and pediatric

See the topic